Latest news with #IonTorrent
The Hindu
07-08-2025
- Business
- The Hindu
TNAU reaches out to innovators under PPP mode to optimise utility of its state-of-the-art Centre for Excellence in Biotechnology
Tamil Nadu Agricultural University has, in the recent months, been reaching out to innovators of unique products through its Centre of Excellence in Biotechnology (COXBIT) for optimising utility of research and product development through public-private partnership mode. The 1.06 facility encompasses knowledge and cabin space which can be occupied by start-ups, student entrepreneurs and established companies for research and development activities. The Centre featuring high-end infrastructure envisages development of super active enzymes / biomolecules, biobased products, hormones for fruit ripening, plant growth stimulants and similar bio-inputs for the commercial benefit of farmers. The common facilities also encompass a conference hall, cafeteria, internet, wi-fi, and instrumentation facilities, said N. Senthil, Director, Centre for Plant Molecular Biology and Biotechnology that runs the facility. On Wednesday, the COXBIT entered into a pact with a Coimbatore-based innovator Nivedita Arjunan, to facilitate research and development of natural ingredient-based perfumes to develop eco-friendly fragrances using botanicals, promoting innovation and value addition in the fragrance sector. Earlier this month, the COXBIT tied up with Sherpa Biotech, a leader in imported button mushroom spawn and modern cultivation, to expand its research by focusing on IoT-based monitoring, stimulants, and smart watering technologies. This new initiative, according to Vendan, Registrar and acting Vice-Chancellor, is expected to increase mushroom production and shelf life, while also promoting agricultural development through the application of modern biotechnologies. Late last month, the COXBIT inked an agreement with Adamsindia AI Company, a leading company in agricultural technology development, for nurturing agricultural sector based on Artificial Intelligence and Machine Learning technology. Earlier during July, an MoU was signed with M/s. Yaazh Xenomics, Coimbatore, specialising in genomic research and DNA sequencing using Illumina, Nanopore, and Ion Torrent platforms. With over 100 research publications, the company also manufactures RT-PCR and biotech kits, supporting researchers, clinicians and students. Tamil Nadu Legislative Estimate Committee under the chairmanship of S. Gandhirajan, MLA, while on a visit to TNAU last month, appreciated activities undertaken by the Centre such as digitization of insects, DNA barcoding, and guided audio tour. The insect museum with more than 50,000 preserved insects on various groups is visited with interest by school / college students and farming community. The Assembly team witnessed demonstrations on low cost coconut dehusking machine, drone spraying of nutrients and pesticides, telescopic coconut harvesting machine, and plantrox app for pest and disease diagnosis.
Yahoo
14-07-2025
- Business
- Yahoo
Thermo Fisher Scientific Introduces the Oncomine Comprehensive Assay Plus on the Ion Torrent Genexus System to Help Advance the Future of Precision Medicine
New assay provides clinical research labs with an all-in-one comprehensive genomic profiling solution that delivers next-day results CARLSBAD, Calif., July 14, 2025--(BUSINESS WIRE)--Today, Thermo Fisher Scientific announced that the Oncomine™ Comprehensive Assay Plus* is now available on the Ion Torrent™ Genexus™ System* helping accelerate precision oncology research. The Oncomine Comprehensive Assay Plus detects a broad range of genomic alterations in 517 genes and will now be able to deliver comprehensive genomic profiling (CGP) results as soon as the next day, enabled by Ion Torrent technology and easy, automated workflows. CGP facilitates the simultaneous analysis of a broad range of biomarkers in one test to maximize insights on the underlying oncogenic drivers in a timely manner. Already available on the Ion GeneStudio™ S5 systems*, the Oncomine Comprehensive Assay Plus detects single-nucleotide variants, insertions and deletions, copy number variations, and fusions. Additionally, the assay detects genomic signatures such as homologous recombination deficiency (HRD), tumor mutational burden (TMB) and microsatellite instability (MSI). With the capabilities of the Genexus System, researchers can now detect a broad range of these important biomarkers, quickly and easily. "We have been waiting for this complete and rapid CGP solution that includes all the relevant biomarkers including TMB, MSI and HRD," said Hector M Alcaraz, MS, Founder of Imagene Health, SA de CV, an early access user of the Oncomine Comprehensive Assay Plus on the Genexus System. "This will make CGP more accessible to our local markets so that we can drive the future of precision medicine forward." The Genexus System is an automated and integrated NGS platform capable of delivering NGS results as soon as the next day. With end-to-end automation that requires less hands-on time, the Genexus System makes genomic profiling accessible to more researchers with varying levels of experience. Now, with the Oncomine Comprehensive Assay Plus available on the Genexus System, research teams can leverage this end-to-end solution to deliver accurate and robust CGP results as soon as the next day. "In recent years, new genomic insights have played an essential role in advancing our understanding of human health and driving novel drug development," said Kathy Davy, president of Clinical Next Generation Sequencing at Thermo Fisher Scientific. "The addition of the Oncomine Comprehensive Assay Plus on the Genexus System brings the benefits of rapid CGP to more labs, empowering researchers to leverage more comprehensive results at a much faster pace and accelerate what could be life-saving research." For more information about the Oncomine Comprehensive Assay Plus on the Genexus System and how this is enabling research labs to accelerate oncology research, please visit *For Research Use Only. Not for use in diagnostic procedures. About Thermo Fisher Scientific Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue over $40 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, increasing productivity in their laboratories, improving patient health through diagnostics or the development and manufacture of life-changing therapies, we are here to support them. Our global team delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon and PPD. For more information, please visit View source version on Contacts Media Contact Information:Jen CarrollPhone: (760) 583 - 8898E-mail: Jessika ParryPhone: 419-266-4016Email: jparry@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
